- Clinical Trials
- April 2024
- 60 Pages
Global
From €1820EUR$2,000USD£1,560GBP
- Report
- May 2022
- 83 Pages
Global
From €1820EUR$2,000USD£1,560GBP
The Rhinovirus Drug market is a subset of the Infectious Diseases Drugs market. It is composed of drugs used to treat rhinovirus infections, which are caused by a group of viruses that can cause the common cold. These drugs are typically used to reduce the severity of symptoms, such as nasal congestion, sore throat, and coughing. They may also be used to reduce the duration of the infection.
Rhinovirus drugs are available in a variety of forms, including tablets, capsules, liquids, and nasal sprays. They may be prescribed by a doctor or purchased over-the-counter.
The Rhinovirus Drug market is highly competitive, with many companies offering products to treat rhinovirus infections. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Sanofi, and Novartis. Show Less Read more